Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response

Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes

(2014) Brian R. Lindman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Clinical Implications of Chronic Heart Failure Phenotypes Defined by Cluster Analysis

(2014) Tariq Ahmad et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Olmesartan is More Effective Than Other Angiotensin Receptor Antagonists in Reducing Proteinuria in Patients With Chronic Kidney Disease Other Than Diabetic Nephropathy

(2013) Takashi Ono et al.   CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL

A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

(2013) Walter J. Paulus et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Predictors of New-Onset Heart Failure

(2012) Jennifer E. Ho et al.   Circulation-Heart Failure

What Have We Learned About Patients With Heart Failure and Preserved Ejection Fraction From DIG-PEF, CHARM-Preserved, and I-PRESERVE?

(2012) Ross T. Campbell et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Endothelial Dysfunction

(2012) Carolyn S.P. Lam et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Impact of Noncardiac Comorbidities on Morbidity and Mortality in a Predominantly Male Population With Heart Failure and Preserved Versus Reduced Ejection Fraction

(2012) Sameer Ather et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Personalized BEST: Characterization of Latent Clinical Classes of Nonischemic Heart Failure That Predict Outcomes and Response to Bucindolol

(2012) David P. Kao et al.   PLoS One

Systolic and Diastolic Heart Failure Are Overlapping Phenotypes Within the Heart Failure Spectrum

(2011) Gilles W. De Keulenaer et al.   CIRCULATION

Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection Fraction

(2011) Markus Haass et al.   Circulation-Heart Failure

Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction

(2011) Inder S. Anand et al.   Circulation-Heart Failure

Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction

(2010) Michel Komajda et al.   Circulation-Heart Failure

Epidemiology and clinical course of heart failure with preserved ejection fraction

(2010) Carolyn S.P. Lam et al.   EUROPEAN JOURNAL OF HEART FAILURE

Renoprotective Effects of Various Angiotensin II Receptor Blockers in Patients with Early-Stage Diabetic Nephropathy

(2010) Tsukasa Nakamura et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Multiple imputation using chained equations: Issues and guidance for practice

(2010) Ian R. White et al.   STATISTICS IN MEDICINE

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

(2008) GISSI-HF investigators   LANCET

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

(2008) Barry M. Massie et al.   NEW ENGLAND JOURNAL OF MEDICINE